TransMedics Group, Inc.
NASDAQ:TMDX
165.98 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 241.623 | 93.459 | 30.262 | 25.639 | 23.604 | 13.017 | 7.685 | 6.209 |
| Cost of Revenue
| 87.63 | 28.187 | 9.103 | 9.004 | 9.741 | 7.283 | 5.548 | 5.443 |
| Gross Profit
| 153.993 | 65.272 | 21.159 | 16.635 | 13.863 | 5.734 | 2.137 | 0.766 |
| Gross Profit Ratio
| 0.637 | 0.698 | 0.699 | 0.649 | 0.587 | 0.441 | 0.278 | 0.123 |
| Reseach & Development Expenses
| 36.055 | 26.812 | 22.304 | 18.831 | 19.87 | 13.656 | 14.957 | 15.637 |
| General & Administrative Expenses
| 119.553 | 51.688 | 38.283 | 24.188 | 21.524 | 12.315 | 7.606 | 0 |
| Selling & Marketing Expenses
| -2.1 | 18.209 | 8.604 | 0.931 | 2.072 | 1.023 | 0.674 | 0 |
| SG&A
| 117.453 | 69.897 | 38.283 | 24.188 | 23.596 | 12.315 | 7.606 | 8.115 |
| Other Expenses
| 0.047 | -1.002 | -0.877 | 1.653 | 0.79 | -0.213 | 0.548 | 0.005 |
| Operating Expenses
| 153.508 | 96.709 | 60.587 | 43.019 | 43.466 | 25.971 | 22.563 | 23.752 |
| Operating Income
| 0.485 | -31.437 | -39.428 | -26.384 | -29.603 | -20.237 | -20.426 | -22.986 |
| Operating Income Ratio
| 0.002 | -0.336 | -1.303 | -1.029 | -1.254 | -1.555 | -2.658 | -3.702 |
| Total Other Income Expenses Net
| -27.156 | -4.728 | -4.751 | -2.332 | -3.904 | -0.758 | 0.707 | -0.1 |
| Income Before Tax
| -26.671 | -36.165 | -44.179 | -28.716 | -33.507 | -23.715 | -20.791 | -24.065 |
| Income Before Tax Ratio
| -0.11 | -0.387 | -1.46 | -1.12 | -1.42 | -1.822 | -2.705 | -3.876 |
| Income Tax Expense
| -1.643 | 0.066 | 0.036 | 0.032 | 0.04 | 0.041 | 0.032 | 0.984 |
| Net Income
| -25.028 | -36.231 | -44.215 | -28.748 | -33.547 | -23.756 | -20.823 | -24.065 |
| Net Income Ratio
| -0.104 | -0.388 | -1.461 | -1.121 | -1.421 | -1.825 | -2.71 | -3.876 |
| EPS
| -0.77 | -1.23 | -1.6 | -1.16 | -2.36 | -1.23 | -1.44 | -1.66 |
| EPS Diluted
| -0.77 | -1.23 | -1.6 | -1.16 | -2.36 | -1.23 | -1.44 | -1.66 |
| EBITDA
| 8.762 | -32.439 | -40.305 | -24.731 | -28.813 | -19.681 | -19.248 | -22.555 |
| EBITDA Ratio
| 0.036 | -0.347 | -1.332 | -0.965 | -1.221 | -1.512 | -2.505 | -3.633 |